Egypt: SCZone launches 1st roadshow for FY2025/26 in China to attract major investments
The authority mainly aims to draw in investments in the fields of textiles, ready-made garments, automotive, ports, and logistics services.
During his tour, Waleid Gamal El-Dien, the Chairman of the SCZone, discussed Hong Kong-based Crystal International's plans to establish a textile factory on an area of 1.5 million square meters in the Qantara West zone, with expected investments ranging between $250 and $300 million.
The project is expected to offer job opportunities for 30,000-35,000 people.
The Chairman also inspected the Shenzhen Qianhai Exhibition Hall, hosted by the Qianhai Authority, to review the development projects in the Qianhai Special Economic Zone, which include industrial, logistics, and port-related activities.
He also visited the Yantian International Container Terminals, which is managed by the global operator Hutchison, the same operator of the Sokhna Port Container Terminal.
The terminal boasts a 1,200-meter quay length and a yard area of 720,000 square meters, with an investment cost of $250 million. It is expected to open soon.
The first day of the SCZone delegation's tour of Shenzhen concluded with a visit to BYD's headquarters, where they learned about the company's leading products in the electric vehicle (EV) industry.
BYD also specializes in the manufacture of electric car batteries, storage batteries, and solar panels.
Moreover, Gamal El-Dien met with the company's officials to discuss its presence in the SCZone as a gateway to reach African and Middle Eastern markets.
He emphasized that the company's investment in the zone will strengthen the establishment of a major industrial base, including the manufacture of EVs, electric car batteries, and solar panels.
© 2020-2023 Arab Finance For Information Technology. All Rights Reserved. Provided by SyndiGate Media Inc. (Syndigate.info).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
38 minutes ago
- Zawya
Minapharm's majority shareholder Triquera raises capital through minority stake investment from Admaius Capital Partners
Cairo, Egypt - Admaius Capital Partners ('Admaius'), an Africa-focused private equity investor, and Triquera B.V. ('Triquera'), the majority shareholder in Minapharm Pharmaceuticals and Chemical Industries S.A.E. ('Minapharm'), a leading biopharmaceutical company in the Middle East and Africa and a global provider of proprietary technologies to leading biopharma players, today announced a strategic partnership following Admaius' investment in Triquera B.V. For over two decades, Minapharm has established a robust biopharmaceutical platform that combines world-class R&D with end-to-end manufacturing capabilities for complex genetically engineered therapeutic recombinant proteins and viral vectors as well as small molecules with advanced galenic formulations, operating across facilities in Cairo and Berlin. Today, Minapharm operates the largest biological drug substance and drug product facilities in the Middle East and Africa. Through its international subsidiaries, Minapharm licenses out proprietary technologies in the fields of monoclonal antibodies, vaccines, and cell and gene therapies. These technologies enable the development and production of advanced biologics that address critical unmet medical needs globally and have been incorporated into FDA-approved products, underscoring their clinical relevance and global impact. Together, Triquera and Admaius will focus on accelerating the development and production of complex genetically engineered therapies, while expanding access to high-quality, affordable recombinant proteins by investing in innovation and scaling distribution to better serve patients across underserved markets in Africa and the Middle East. In parallel, the partnership will pursue strategic acquisitions of global contract development and manufacturing organizations (CDMOs) to support Minapharm's growth in the biotech sector. This partnership reflects a shared commitment to advancing healthcare equity through innovation and aligns closely with Admaius' broader strategy of supporting mission-driven businesses and management teams in high-impact sectors across the African continent. Zilla Capital acted as the sole financial advisor to Triquera B.V. and the existing shareholders. Matouk Bassiouny served as legal counsel to Triquera B.V. and the existing shareholders. Admaius Capital Partners was advised by White and Case LLP as legal counsel and by Arthur D. Little as commercial advisor. Commenting on the investment: Dr. Wafik Bardissi, Chairman and CEO of Minapharm, said: "This partnership reflects the accelerating momentum of Minapharm's growth as we extend our leadership in biotherapeutics, cell and gene therapies, and proprietary platform technologies. With Admaius, we gain not only capital but a strategic partner whose insight, alignment, and ambition match our own. Together, we are advancing regional self-sufficiency and expanding the global reach of our innovations." Marlon Chigwende, Managing Partner of Admaius, said: 'This is a landmark transaction. The founding families have built a unique asset on the African and European continents that combines scale, growth and impact to fight cancer and other awful diseases. We are pleased to be able to partner with Triquera, Dr. Wafik and Dr. Shaheer and will help to internationalize and grow the business further.' Ahmed Rady, Managing Director of Admaius, said: 'At Admaius, we back exceptional management teams—and the team behind Minapharm is as impressive as the science, technology, and capabilities they've built across Cairo and Berlin. This partnership is about scaling a homegrown champion that combines cutting-edge global know-how with end-to-end manufacturing excellence. We're excited to support Minapharm in taking this next big step and look forward to working closely with the management team.' Dr. Shaheer Bardissi, Co-CEO of Minapharm, added: 'This strategic collaboration with Admaius will accelerate and scale Minapharm's vision of translating cutting-edge scientific innovation into affordable therapies, while advancing global scientific frontiers in immunotherapy as well as advanced therapy medicinal products, for the benefit of the broader biopharmaceutical industry.' Contacts For more information, please contact: Minapharm Christina Azmy cazmy@ (+2) (02) 24143170 Admaius Hannah Gilkes Phone number: +44 7515 958912
Zawya
38 minutes ago
- Zawya
Egypt: Midar partners with Adeer to develop Boulevard project in Mostakbal City with $1.43bln investment
Egypt - Midar for Investment and Urban Development, the master developer of Mostakbal City and MADA City in East Cairo, has announced the signing of a strategic revenue-sharing agreement with Adeer International, a subsidiary of Saudi-based Sumou Holding. The partnership will see the development of an integrated mixed-use urban project spanning over half a million square metres in Mostakbal City, with total investments exceeding EGP 70bn. Ayman ElKousey, CEO and Managing Director of Midar, highlighted the company's commitment to partnering with leading investors and developers who have proven track records in local and regional markets. He noted that Midar's cities—Mostakbal City and MADA—continue to position themselves as top investment destinations in New Cairo, attracting dozens of major investors over recent years thanks to their unique offering focused on sustainability, luxury, and smart infrastructure management. ElKousey added that the agreement reflects Sumou Holding's confidence in Midar's vision and projects. It comes as part of a broader investment alliance launched earlier this year, which brought together Midar, Sumou Investment, Adeer International, and Hassan Allam Properties to develop luxury hospitality and entertainment projects across premium Nile-front locations and within Midar's cities, with total investments of $2bn as announced in the memorandum of understanding signed at the start of the year. He also noted that unveiling the new project during a meeting between the leadership of Sumou Holding Group and Midar, alongside Egypt's Prime Minister Mostafa Madbouly, demonstrates the high level of official attention the project is receiving, as well as the extensive government coordination aimed at ensuring the successful completion of all its phases. ElKousey stressed that the meeting reflected the Egyptian state's commitment to supporting serious investments and overcoming any challenges that might slow progress in key projects. Commenting on the announcement, Bassel El Serafy, CEO of Adeer International, said: 'Our partnership with Midar is built on a shared strategic vision and deep mutual trust in Egypt's real estate and investment potential. Boulevard is not just a flagship development; it represents a long-term ambition to redefine modern living in Egypt through fully integrated, sustainable, and smart urban planning.' El Serafy also announced the establishment of a new joint venture between Adeer International and Paragon Developments to lead the Boulevard project. This step forms part of Sumou Holding's wider strategy—executed through Sumou International Investment—to foster impactful Egyptian-Saudi partnerships, transfer expertise, and deliver flexible, future-ready urban models aligned with the sustainable development goals of both countries. © 2025 Daily News Egypt. Provided by SyndiGate Media Inc. (
Zawya
38 minutes ago
- Zawya
Egypt: DOJA Developments launches Galini project in North Coast
Egypt - DOJA Developments has announced the launch of its latest project, Galini, located in the Sidi Abdel Rahman area on Egypt's North Coast. The mixed-use residential, touristic, and hotel resort is set to receive total investments of EGP 1.5bn. Mahmoud Adel, Chairperson of DOJA Developments, highlighted that the project's strategic location supports year-round occupancy and strengthens its appeal as a promising real estate and tourism investment. This aligns with the state's broader vision to transform the North Coast into a year-round destination, rather than being active only during the summer months. Adel noted that Galini enjoys a prime location—approximately 15 minutes from New Alamein City and around two hours from Cairo. The development will include 160 serviced residential units designed to offer the highest standards of luxury and comfort, alongside a hotel comprising 110 rooms. He added that the company has introduced flexible payment plans tailored to meet the needs of different customer segments. Galini will also offer a full suite of hotel and entertainment amenities, including full room service, a modern gym, underground parking, an indoor restaurant, an outdoor café, a poolside bar, a dedicated children's play area, and a commercial zone featuring a range of restaurants and retail outlets. Adel also announced a partnership with FM Plus, a subsidiary of Concrete Plus, to oversee the project's operations and maintenance. Leveraging its deep expertise in facilities management, FM Plus will play a key role in safeguarding the project's investment value and maintaining the highest service quality standards. In addition, DOJA Developments has partnered with Azal Hotels & Resorts, a subsidiary of the Garrana Group, to manage and operate the hotel component of Galini. This collaboration aims to deliver a hospitality experience that meets top international standards. The company is offering competitive payment options, starting with a 10% down payment and instalments over eight years, coupled with prices described as among the most attractive in the North Coast market. Adel concluded by noting that the land for the project has been fully paid for and that Galini will be entirely self-financed, drawing on DOJA Developments' established track record in the market. The project's smartly designed units, featuring compact layouts, are aimed at buyers seeking affordable and flexible ownership opportunities on the North Coast.
